Multidisciplinary Management of Soft Tissue Sarcoma

Soft tissue sarcoma is a rare malignancy, with approximately 11,000 cases per year encountered in the United States. It is primarily encountered in adults but can affect patients of any age. There are many histologic subtypes and the malignancy can be low or high grade. Appropriate staging work up i...

Full description

Saved in:
Bibliographic Details
Main Authors: Lukas M. Nystrom, Nickolas B. Reimer, John D. Reith, Long Dang, Robert A. Zlotecki, Mark T. Scarborough, C. Parker Gibbs
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/852462
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558807828398080
author Lukas M. Nystrom
Nickolas B. Reimer
John D. Reith
Long Dang
Robert A. Zlotecki
Mark T. Scarborough
C. Parker Gibbs
author_facet Lukas M. Nystrom
Nickolas B. Reimer
John D. Reith
Long Dang
Robert A. Zlotecki
Mark T. Scarborough
C. Parker Gibbs
author_sort Lukas M. Nystrom
collection DOAJ
description Soft tissue sarcoma is a rare malignancy, with approximately 11,000 cases per year encountered in the United States. It is primarily encountered in adults but can affect patients of any age. There are many histologic subtypes and the malignancy can be low or high grade. Appropriate staging work up includes a physical exam, advanced imaging, and a carefully planned biopsy. This information is then used to guide the discussion of definitive treatment of the tumor which typically involves surgical resection with a negative margin in addition to neoadjuvant or adjuvant external beam radiation. Advances in imaging and radiation therapy have made limb salvage surgery the standard of care, with local control rates greater than 90% in most modern series. Currently, the role of chemotherapy is not well defined and this treatment is typically reserved for patients with metastatic or recurrent disease and for certain histologic subtypes. The goal of this paper is to review the current state of the art in multidisciplinary management of soft tissue sarcoma.
format Article
id doaj-art-7aee29dd5c5b4922940fd338f1414835
institution Kabale University
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-7aee29dd5c5b4922940fd338f14148352025-02-03T01:31:35ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/852462852462Multidisciplinary Management of Soft Tissue SarcomaLukas M. Nystrom0Nickolas B. Reimer1John D. Reith2Long Dang3Robert A. Zlotecki4Mark T. Scarborough5C. Parker Gibbs6Orthopaedic & Sports Medicine Institute, University of Florida, 3450 Hull Road, Gainesville, FL 32605, USAOrthopaedic & Sports Medicine Institute, University of Florida, 3450 Hull Road, Gainesville, FL 32605, USADepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL 32608, USADepartment of Medicine, Division of Hematology & Oncology, University of Florida, 1600 SW Archer Road, Gainesville, FL 32608, USADepartment of Radiation Oncology, University of Florida, 1600 SW Archer Road, Gainesville, FL 32608, USAOrthopaedic & Sports Medicine Institute, University of Florida, 3450 Hull Road, Gainesville, FL 32605, USAOrthopaedic & Sports Medicine Institute, University of Florida, 3450 Hull Road, Gainesville, FL 32605, USASoft tissue sarcoma is a rare malignancy, with approximately 11,000 cases per year encountered in the United States. It is primarily encountered in adults but can affect patients of any age. There are many histologic subtypes and the malignancy can be low or high grade. Appropriate staging work up includes a physical exam, advanced imaging, and a carefully planned biopsy. This information is then used to guide the discussion of definitive treatment of the tumor which typically involves surgical resection with a negative margin in addition to neoadjuvant or adjuvant external beam radiation. Advances in imaging and radiation therapy have made limb salvage surgery the standard of care, with local control rates greater than 90% in most modern series. Currently, the role of chemotherapy is not well defined and this treatment is typically reserved for patients with metastatic or recurrent disease and for certain histologic subtypes. The goal of this paper is to review the current state of the art in multidisciplinary management of soft tissue sarcoma.http://dx.doi.org/10.1155/2013/852462
spellingShingle Lukas M. Nystrom
Nickolas B. Reimer
John D. Reith
Long Dang
Robert A. Zlotecki
Mark T. Scarborough
C. Parker Gibbs
Multidisciplinary Management of Soft Tissue Sarcoma
The Scientific World Journal
title Multidisciplinary Management of Soft Tissue Sarcoma
title_full Multidisciplinary Management of Soft Tissue Sarcoma
title_fullStr Multidisciplinary Management of Soft Tissue Sarcoma
title_full_unstemmed Multidisciplinary Management of Soft Tissue Sarcoma
title_short Multidisciplinary Management of Soft Tissue Sarcoma
title_sort multidisciplinary management of soft tissue sarcoma
url http://dx.doi.org/10.1155/2013/852462
work_keys_str_mv AT lukasmnystrom multidisciplinarymanagementofsofttissuesarcoma
AT nickolasbreimer multidisciplinarymanagementofsofttissuesarcoma
AT johndreith multidisciplinarymanagementofsofttissuesarcoma
AT longdang multidisciplinarymanagementofsofttissuesarcoma
AT robertazlotecki multidisciplinarymanagementofsofttissuesarcoma
AT marktscarborough multidisciplinarymanagementofsofttissuesarcoma
AT cparkergibbs multidisciplinarymanagementofsofttissuesarcoma